Highlights and Quick Summary
- Net Income for the quarter ending June 30, 2022 was $932 Million (a -79.14% decrease compared to previous quarter)
- Year-over-year quarterly Net Income decreased by -70.49%
- Annual Net Income for 2021 was $11.5 Billion (a 151.71% increase from previous year)
- Annual Net Income for 2020 was $4.56 Billion (a -41.9% decrease from previous year)
- Annual Net Income for 2019 was $7.84 Billion (a 38.62% increase from previous year)
- Twelve month Net Income ending June 30, 2022 was $12.6 Billion (a 1.48% increase compared to previous quarter)
- Twelve month trailing Net Income increased by 67.75% year-over-year
Trailing Net Income for the last four month:
30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
---|---|---|---|
$12.6 Billion | $12.4 Billion | $11.5 Billion | $7.5 Billion |
Visit stockrow.com/ABBV
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Income of AbbVie Inc.
Most recent Net Incomeof ABBV including historical data for past 10 years.Interactive Chart of Net Income of AbbVie Inc.
AbbVie Inc. Net Income for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $932.0 | $4,468.0 | – | – | – |
2021 | $4,023.0 | $3,158.0 | $749.0 | $3,555.0 | $11,468.0 |
2020 | $38.0 | $2,313.0 | $-739.0 | $3,010.0 | $4,556.0 |
2019 | $2,801.0 | $1,884.0 | $741.0 | $2,456.0 | $7,842.0 |
2018 | $-1,826.0 | $2,747.0 | $1,983.0 | $2,783.0 | $5,657.0 |
2017 | $52.0 | $1,631.0 | $1,915.0 | $1,711.0 | $5,283.0 |
2016 | $1,391.0 | $1,598.0 | $1,610.0 | $1,354.0 | $5,953.0 |
2015 | $1,517.0 | $1,239.0 | $1,366.0 | $1,022.0 | $5,144.0 |
2014 | $-810.0 | $506.0 | $1,098.0 | $980.0 | $1,774.0 |
2013 | $1,128.0 | $964.0 | $1,068.0 | $968.0 | $4,128.0 |
2012 | $1,540.0 | $1,585.0 | $1,267.0 | $883.0 | $5,275.0 |
2011 | $1,157.56 | $12.34 | – | – | $3,433.0 |
Business Profile of AbbVie Inc.
Sector: Healthcare
Industry: Drug Manufacturers General